HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effect of colloid bismuth treatment on Campylobacter pylori infection of the gastric mucosa and the clinical course of non-ulcer dyspepsia].

Abstract
There are suggestions, that the idiopathic non-ulcer dyspepsia is related to the chronic gastritis type B coexisting with C. pylori infection. Presented studies were aimed at the assessing of an effect of the treatment with De-Nol on the course of the idiopathic non-ulcer dyspepsia of C. pylori infection. Gastroscopic examination was performed in 52 patients with non-ulcer dyspepsia before and after the treatment with De-Nol administered for 4-8 weeks. Campylobacter pylori was isolated from 71% of patients with idiopathic non-ulcer dyspepsia. An infection was eradicated in 97.4% of patients treated with De-Nol. The number of dyspeptic episodes decreased in by 96% of patients, including 33% of patients in whom total recovery was noted. De-Nol was well tolerated. De-Nol is highly effective in the eradication of C. pylori and produces clinical improvement in the majority of patients with non-ulcer dyspepsia.
AuthorsJ Muszyński, D Biernacka, E Bogacka-Zatorska, M Stepka, A Galczak, L Zalewski, K Lissowska, A Ehrmann
JournalPolski tygodnik lekarski (Warsaw, Poland : 1960) (Pol Tyg Lek) 1992 Jan 20-27 Vol. 47 Issue 3-4 Pg. 75-8 ISSN: 0032-3756 [Print] Poland
Vernacular TitleWpływ leczenia bizmutem koloidalnym na zakaåenie błony śluzowej zoładka przez Campylobacter pylori i przebieg kliniczny idiopatycznej dyspepsji niewrzodowej.
PMID1437790 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Antacids
  • Organometallic Compounds
  • bismuth tripotassium dicitrate
Topics
  • Adolescent
  • Adult
  • Aged
  • Antacids (therapeutic use)
  • Chronic Disease
  • Dyspepsia (drug therapy, etiology)
  • Female
  • Gastric Mucosa (drug effects)
  • Gastritis (complications, drug therapy)
  • Helicobacter Infections (complications, drug therapy)
  • Humans
  • Male
  • Middle Aged
  • Organometallic Compounds (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: